Motoki Nakao
-
- Immunotherapy and Immune Responses 4
- Clinical Biochemistry top 10%
-
- RNA Interference and Gene Delivery 3
-
- Cardiac electrophysiology and arrhythmias 6
- Cardiac Arrhythmias and Treatments 5
- Heart Failure Treatment and Management 5
- Atrial Fibrillation Management and Outcomes 4
- Cardiovascular Function and Risk Factors 4
-
- Diabetes Treatment and Management 4
- Co-authors
- Yoshimasa ItoShigeki ShichijoMasayuki TomohiroTomohiro NabekuraHajime MatsumotoDamu YangHideaki YamanaTeruo Sasatomi
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Motoki Nakao
26 papers receiving 479 citations
Peers
Comparison fields: 5 of 78
- Immunology 199
- Clinical Biochemistry 43
- Molecular Biology 242
- Oncology 75
- Cardiology and Cardiovascular Medicine 61
Countries citing papers authored by Motoki Nakao
This map shows the geographic impact of Motoki Nakao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoki Nakao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoki Nakao more than expected).
Fields of papers citing papers by Motoki Nakao
This network shows the impact of papers produced by Motoki Nakao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoki Nakao. The network helps show where Motoki Nakao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Motoki Nakao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 37 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 0 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 2 | |
| 15 | 2003 | 41 | |
| 16 | 2001 | 54 | |
| 17 | 1999 | 43 | |
| 18 | 1996 | 29 | |
| 19 | 1993 | 66 | |
| 20 | A study of ELISA for schistosomiasis japónica using O-phenylenediamine, a substrate of peroxidase-labeled antibody. | 1982 | 0 |
About Motoki Nakao
Motoki Nakao is a scholar working on Cardiology and Cardiovascular Medicine, Parasitology and Hematology, having authored 33 papers that have together received 492 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (6 papers), Cardiac Arrhythmias and Treatments (5 papers), Heart Failure Treatment and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers), Cardiovascular Function and Risk Factors (4 papers), Immunotherapy and Immune Responses (4 papers), Diabetes Treatment and Management (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Immunology (199 citations), Clinical Biochemistry (43 citations) and Molecular Biology (242 citations). Motoki Nakao has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Yoshimasa Ito, Shigeki Shichijo, Masayuki Tomohiro, Tomohiro Nabekura, Hajime Matsumoto, Damu Yang, Hideaki Yamana, Teruo Sasatomi, Hideo Takasu and Kanji Mori. Their work appears in journals such as Circulation, The Journal of Immunology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.